These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18816776)

  • 21. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To what extent are genetics clinically useful?
    Vermeire S
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S8-14. PubMed ID: 21640929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of inflammatory bowel disease: progress and prospects.
    Mathew CG; Lewis CM
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R161-8. PubMed ID: 14764625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finding inflammatory bowel disease genes will not lead to a cure.
    Marshall JK
    Can J Gastroenterol; 2006 Oct; 20(10):643-4. PubMed ID: 17066154
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutational analyses of novel rat models with targeted modifications in inflammatory bowel disease susceptibility genes.
    Men H; Hankins MA; Bock AS; Beaton BP; Davis DJ; Chesney KL; Bryda EC
    Mamm Genome; 2021 Jun; 32(3):173-182. PubMed ID: 33843019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CARD15 genotype-phenotype relationships in a small inflammatory bowel disease population with severe disease affection status.
    Crawford NP; Colliver DW; Eichenberger MR; Funke AA; Kolodko V; Cobbs GA; Petras RE; Galandiuk S
    Dig Dis Sci; 2007 Oct; 52(10):2716-24. PubMed ID: 17404888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the molecular dissection of inflammatory bowel disease.
    Siminovitch KA
    Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant role of genetics in IBD: the NOD2 gene.
    Cho JH
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S18-22. PubMed ID: 12684585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling the complex genetics of inflammatory bowel disease.
    Russell RK; Wilson DC; Satsangi J
    Arch Dis Child; 2004 Jul; 89(7):598-603. PubMed ID: 15210486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric inflammatory bowel disease: clinical and molecular genetics.
    Biank V; Broeckel U; Kugathasan S
    Inflamm Bowel Dis; 2007 Nov; 13(11):1430-8. PubMed ID: 17600381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
    Papp M; Lakatos PL; Harsfalvi J; Farkas G; Palatka K; Udvardy M; Molnar T; Farkas K; Nagy F; Veres G; Lakatos L; Kovacs A; Dinya T; Kocsis AK; Papp J; ; Altorjay I
    Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The "soft collagen" hypothesis in the pathogenesis of the inflammatory bowel disease and the seronegative spondylarthritides.
    Vounotrypidis P; Kouklakis G
    Med Hypotheses; 2010 Sep; 75(3):284-6. PubMed ID: 20334983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is genetic testing in IBD ready for prime time?
    Abreu MT; Yang H
    Am J Gastroenterol; 2004 Feb; 99(2):316-8. PubMed ID: 15046223
    [No Abstract]   [Full Text] [Related]  

  • 35. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.
    Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M;
    Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finding inflammatory bowel disease genes will lead to a cure.
    Cho J
    Can J Gastroenterol; 2006 Oct; 20(10):641-2. PubMed ID: 17066153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
    Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S
    Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors?
    Macho Fernandez E; Pot B; Grangette C
    Gut Microbes; 2011 Sep; 2(5):280-6. PubMed ID: 22067939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population.
    O'Callaghan NJ; Adams KE; van Heel DA; Cavanaugh JA
    Scand J Gastroenterol; 2003 May; 38(5):533-4. PubMed ID: 12795465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.